Dr. Langer on Afatinib for Advanced Non-Small Cell Lung Cancer

0 Views
administrator
administrator
07/14/23

Corey Langer, MD, the director of Thoracic Oncology at the University of Pennsylvania, discuses afatinib, which was recently approved for first line EGFR-mutated advanced non-small cell lung cancer.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next